CONFORMAL RADIATION THERAPY WITH INDIVIDUAL PLANNING OF TARGET VOLUME FOR LOCALLY ADVANCED NON-METASTATIC PROSTATE CANCER: TRANSFORMATION OF CLINICAL SYMPTOMS AND A CHANGE IN THE QUALITY OF LIFE IN PATIENTS AT THE STAGE OF RADIATION TREATMENT (38-41)

Архив в PDF формате
Дата публикации статьи в журнале: 2019/10/11
Название журнала: Восточно Европейский Научный Журнал, Выпуск: 49, Том: 1, Страницы в выпуске: 38-41
Автор: Trofymov A.
, Grigoriev Institute for medical Radiology NAMS of Ukraine ,
Автор: Starenkiy V.
, Grigoriev Institute for medical Radiology NAMS of Ukraine , doctor of medicine
Автор: Svynarenko A.
, Grigoriev Institute for medical Radiology NAMS of Ukraine ,
Анотация: The aim of this study was to determine the effect of treatment on the clinical course of the disease and a change in the quality of life in patients who underwent two types of treatment planning: traditional (planning for conventional radiation therapy without monitoring the position of the target volume isocenter) and developed by us, the one which allows the planning for the 3D CRT course followed by monitoring the position of the target volume in the interfractional period. Assessment of quality of life in patients who underwent a course of EBRT with special radiation treatment planning method was carried out using the IPSS scale (International Prostate Symptom Score), which allows the determination the severity of symptoms in patients with urination disorder. Evaluation of a quality of life index was used as an additional method. The incidence rate of the reported disorders in the group of patients with individual treatment planning decreased 2.1 times (from 73% to 34.9%, respectively), while in the control group this rate barely reached 1.3 times (from 68.6% to 51.4%, respectively).
Ключевые слова: External beam radiation therapy   treatment planning   target volume   prostate cancer  
Данные для цитирования: Trofymov A. , Starenkiy V. , Svynarenko A. . CONFORMAL RADIATION THERAPY WITH INDIVIDUAL PLANNING OF TARGET VOLUME FOR LOCALLY ADVANCED NON-METASTATIC PROSTATE CANCER: TRANSFORMATION OF CLINICAL SYMPTOMS AND A CHANGE IN THE QUALITY OF LIFE IN PATIENTS AT THE STAGE OF RADIATION TREATMENT (38-41). Восточно Европейский Научный Журнал. Медицинские науки. 2019/10/11; 49(1):38-41.

Список литературы: 1. Kulik A, Dąbkowski M. Prostate cancer radiotherapy. Contemp Oncol (Pozn) 2011; 15: 317-22. 2. Hoskin PJ, Rojas AM, Ostler PJ, Hughes R, Lowe GJ, Bryant L. Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomized trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy. Clin Oncol (R Coll Radiol) 2013; 25: 321-7. 3. Pawlowski JM, Yang ES, Malcolm AW, Coffey CW, Ding GX. “Reduction of dose delivered to organs at risk in prostate cancer via image-guided radiation therapy,” International Journal of Radiation Oncology Biology Physics. vol. 76, no. 3, pp. 924-934, 2010. 4. Fu W, Yang Y, Yue NJ, Heron DE, Huq MS. A cone beam CT-guided online plan modification technique to correct interfractional anatomic changes for prostate cancer IMRT treatment. Phys Med Biol. 2009;54(6):1691-1703. 5. Valdagni R, Kattan MW, Rancati T, Yu C, Vavassori V, Fellin G, Cagna E, Gabriele P, Mauro FA, Baccolini M, Bianchi C, Menegotti L, Monti AF, Stasi M, Giganti MO, Fiorino C. Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys, 2012; 82: 1957–1966. 6. Martinez AA, Gonzalez J, Ye H, Ghilezan M, Shetty S, Kernen K, et al. Dose escalation improves cancer-related events at 10 years for intermediate- and high risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79:363–70. 7. Zapatero A, Roch M, Buchser D, et al. Reduced late urinary toxicity with high-dose intensitymodulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer. Clin Transl Oncol. 2017;19:1161–7. 8. Murakami N, Itami J, Okuma K, Hiroshi M, Keiichi N, Tsukasa B, et al. Urethral dose and increment of international prostate symptom score (IPSS) in transperineal permanent interstitial implant (TPI) of prostate cancer. Strahlenther Onkol. 2008;184:515–9. 9. Malik R, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS). Int J Radiat Oncol Biol Phys, 2011; 80: 1080– 1086. 10. Schaake W, de Groot M, Krijnen WP, Langendijk JA, van den Bergh AC. Quality of life among prostate cancer patients: A prospective longitudinal population-based study. Radiother Oncol 2013; 108: 299-305.